CHICAGO—Prevent Blindness has announced the appointment of six new members to its board of directors, finalized through a vote at its annual board meeting on Nov. 18. New board members include Karen Allison, MD, MBA, FACS, Flaum Eye Institute at the University of Rochester; C. Edward Buffington, president and CEO, GPN Technologies; Sue Downes, co-founder and CEO, MyEyeDr.; Stephanie Marioneaux, MD, private practice owner, assistant professor of ophthalmology at Eastern Virginia Medical School; Kim Schuy Greenberg, CEO, Delasco; and Dean A. VanNasdale, Jr., OD, PhD, MS, FAAO, associate professor at The Ohio State University College of Optometry.

Joan Wahlman, president of JD Healthcare Consultants and a member of the Prevent Blindness Texas board of directors, was elected as the chief volunteer officer liaison and voting member of the national board. Amy Pulles, president and CEO of Prevent Blindness Ohio, was elected as the new Prevent Blindness affiliate board liaison. In recognition of their service to Prevent Blindness, James E. Anderson, partner at Howe, Anderson & Smith, P.C. and Paul Howes, EVP, strategy and business development at Translatum Medicus Inc., were elected as Prevent Blindness emeritus members of the board of directors.

“The Prevent Blindness board of directors is an esteemed group of leaders dedicated to advancing our mission to prevent blindness and preserve sight,” said Jeff Todd, president and CEO. “We enthusiastically welcome our new members as they guide us in our work and provide insight and expertise on the best ways to advocate for patients and break down the barriers to eyecare that far too many people encounter.”

For a full listing of members of the Prevent Blindness board of directors, click here. For more information about Prevent Blindness or general eye health information, click here.










(Clockwise from top left) The new Prevent Blindness board of director members include Karen Allison, MD; C. Edward Buffington, president and CEO, GPN Technologies; Sue Downes, co-founder, MyEyeDr.; Dean A. VanNasdale, Jr., OD; Kim Schuy Greenberg, CEO, Delasco; and Stephanie Marioneaux, MD.